European Stroke Organisation (ESO) guideline on screening for subclinical atrial fibrillation after stroke or transient ischaemic attack of undetermined origin

M Rubiera, A Aires, K Antonenko… - European Stroke …, 2022 - journals.sagepub.com
We aimed to provide practical recommendations for the screening of subclinical atrial
fibrillation (AF) in patients with ischaemic stroke or transient ischaemic attack (TIA) of …

The impact of SGLT2 inhibition on imaging markers of cardiac function: A systematic review and meta-analysis

P Theofilis, AS Antonopoulos, T Katsimichas… - Pharmacological …, 2022 - Elsevier
Objectives The use of sodium-glucose cotransporter-2 inhibitors (SGLT2-Is) has resulted in
significant benefits in patients with heart failure irrespective of left ventricular ejection fraction …

Atrial fibrillation in patients with embolic stroke of undetermined source during 3 years of prolonged monitoring with an implantable loop recorder

A Kitsiou, A Rogalewski, M Kalyani… - Thrombosis and …, 2021 - thieme-connect.com
Background Undocumented atrial fibrillation (AF) is suspected as a main stroke cause in
patients with embolic stroke of undetermined source (ESUS), but its prevalence is largely …

[PDF][PDF] 心房颤动患者左心房形态结构及功能与血栓形成关系的研究进展

杨敏, 肖模超 - 临床心血管病杂志, 2023 - lcxxg.whuhzzs.com
心房颤动(房颤) 是最常见的心律失常之一, 而血栓事件是房颤患者最严重的并发症.
目前临床上主要通过CHA2DS2-VASc 评分指导抗凝治疗, 但有较多不足. 有研究发现左心房的 …

One-stop management of 230 consecutive acute stroke patients: report of procedural times and clinical outcome

MN Psychogios, IL Maier, I Tsogkas, AC Hesse… - Journal of clinical …, 2019 - mdpi.com
Background and purpose: Rapid thrombectomy for acute ischemic stroke caused by large
vessel occlusion leads to improved outcome. Optimizing intrahospital management might …

Left atrial volume index predicts new-onset atrial fibrillation and stroke recurrence in patients with embolic stroke of undetermined source

BYQ Tan, JSY Ho, CH Sia, Y Boi, ASM Foo… - Cerebrovascular …, 2020 - karger.com
Introduction: It is unclear which surrogate of atrial cardiopathy best predicts the risk of
developing a recurrent ischemic stroke in embolic stroke of undetermined source (ESUS) …

Fibrosis, atrial fibrillation and stroke: clinical updates and emerging mechanistic models

PM Boyle, JC Del Álamo, N Akoum - Heart, 2021 - heart.bmj.com
The current paradigm of stroke risk assessment and mitigation in patients with atrial
fibrillation (AF) is centred around clinical risk factors which, in the presence of AF, lead to …

Prevalence of markers of atrial cardiomyopathy in embolic stroke of undetermined source: a systematic review

N Stalikas, I Doundoulakis, E Karagiannidis… - European Journal of …, 2022 - Elsevier
Background Emerging evidence suggests the potential role of atrial cardiomyopathy (AC) as
a direct thromboembolic determinant in embolic stroke of undetermined source (ESUS) …

Predicting atrial fibrillation with high risk of embolization with atrial strain and NT-proBNP

J Pagola, J Juega, J Francisco-Pascual… - Translational stroke …, 2021 - Springer
The aim of the study was to determine markers of atrial dysfunction in patients with
cryptogenic stroke to predict episodes of paroxysmal atrial fibrillation with high risk of …

Atrial cardiopathy and cryptogenic stroke

Y Kato, S Takahashi - Frontiers in Neurology, 2022 - frontiersin.org
Recent advances in pathophysiology suggest that a pathological atrial substrate can cause
embolic stroke even in patients without atrial fibrillation (AF). This pathological condition is …